Human Pathology, ISSN 0046-8177, 2009, Volume 40, Issue 3, pp. 349 - 355
Summary Loss of SMARCB1/INI1 protein expression is considered useful for confirming a histologic diagnosis of malignant rhabdoid tumor. However, loss of...
Pathology | Malignant rhabdoid tumor | Immunohistochemistry | Epithelioid sarcoma | SMARCB1/INI1 | BLADDER-CANCER | SOFT-TISSUE SARCOMAS | TIME QUANTITATIVE PCR | PATHOLOGY | IMMUNOHISTOCHEMICAL ANALYSIS | CENTRAL-NERVOUS-SYSTEM | CHECKPOINT | HSNF5/INI1 | MUTATIONS | ATYPICAL TERATOID/RHABDOID TUMORS | EXPRESSION | Soft Tissue Neoplasms - diagnosis | Humans | Male | Immunoenzyme Techniques | DNA-Binding Proteins - metabolism | SMARCB1 Protein | Young Adult | DNA Mutational Analysis | Sarcoma - mortality | Biomarkers, Tumor - metabolism | Female | DNA, Neoplasm - analysis | Sarcoma - diagnosis | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Diagnosis, Differential | Soft Tissue Neoplasms - mortality | Chromosomal Proteins, Non-Histone - metabolism | Kaplan-Meier Estimate | Survival Rate | Gene Dosage | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Reverse Transcriptase Polymerase Chain Reaction | Chromosomal Proteins, Non-Histone - genetics | Transcription Factors - metabolism | Rhabdoid Tumor - genetics | Biomarkers, Tumor - genetics | Rhabdoid Tumor - diagnosis | Mutation | Genetic research | Universities and colleges | Sarcoma | DNA | Proteins | Polymerase chain reaction | Survival analysis | Genes | Cell cycle | Epigenetics | Genetics
Pathology | Malignant rhabdoid tumor | Immunohistochemistry | Epithelioid sarcoma | SMARCB1/INI1 | BLADDER-CANCER | SOFT-TISSUE SARCOMAS | TIME QUANTITATIVE PCR | PATHOLOGY | IMMUNOHISTOCHEMICAL ANALYSIS | CENTRAL-NERVOUS-SYSTEM | CHECKPOINT | HSNF5/INI1 | MUTATIONS | ATYPICAL TERATOID/RHABDOID TUMORS | EXPRESSION | Soft Tissue Neoplasms - diagnosis | Humans | Male | Immunoenzyme Techniques | DNA-Binding Proteins - metabolism | SMARCB1 Protein | Young Adult | DNA Mutational Analysis | Sarcoma - mortality | Biomarkers, Tumor - metabolism | Female | DNA, Neoplasm - analysis | Sarcoma - diagnosis | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Diagnosis, Differential | Soft Tissue Neoplasms - mortality | Chromosomal Proteins, Non-Histone - metabolism | Kaplan-Meier Estimate | Survival Rate | Gene Dosage | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Reverse Transcriptase Polymerase Chain Reaction | Chromosomal Proteins, Non-Histone - genetics | Transcription Factors - metabolism | Rhabdoid Tumor - genetics | Biomarkers, Tumor - genetics | Rhabdoid Tumor - diagnosis | Mutation | Genetic research | Universities and colleges | Sarcoma | DNA | Proteins | Polymerase chain reaction | Survival analysis | Genes | Cell cycle | Epigenetics | Genetics
Journal Article
Pathology International, ISSN 1320-5463, 06/2006, Volume 56, Issue 6, pp. 287 - 295
Malignant rhabdoid tumor (MRT) of the soft tissue is a rare and highly aggressive tumor that occurs in infancy or childhood. It predominantly involves a deep...
immunohistochemistry | proximal‐type epithelioid sarcoma | extrarenal rhabdoid tumor | hSNF5/INI1/SMARCB1 | soft tissue tumor | Immunohistochemistry | Soft tissue tumor | Extrarenal rhabdoid tumor | Proximal-type epithelioid sarcoma | proximal-type epithelioid sarcoma | SYNOVIAL SARCOMA | PROGNOSTIC-FACTORS | EXTRASKELETAL MYXOID CHONDROSARCOMA | PATHOLOGY | RENAL-CELL CARCINOMA | IMMUNOHISTOCHEMICAL ANALYSIS | MALIGNANT FIBROUS HISTIOCYTOMA | EPITHELIOID SARCOMA | POLYMERASE CHAIN-REACTION | CENTRAL-NERVOUS-SYSTEM | ATYPICAL TERATOID/RHABDOID TUMORS | Diagnosis, Differential | Molecular Biology | Biomarkers, Tumor - analysis | Humans | Rhabdoid Tumor - chemistry | Chromosomal Proteins, Non-Histone | Child, Preschool | DNA-Binding Proteins - analysis | Infant | Rhabdoid Tumor - pathology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Sarcoma - pathology | SMARCB1 Protein | Sarcoma - chemistry | Rhabdoid Tumor - genetics | Soft Tissue Neoplasms - chemistry | Soft Tissue Neoplasms - pathology | Cytogenetics | Transcription Factors - analysis | Mutation | Sarcoma - genetics | Child | Soft Tissue Neoplasms - genetics | Sarcoma | Genetic research
immunohistochemistry | proximal‐type epithelioid sarcoma | extrarenal rhabdoid tumor | hSNF5/INI1/SMARCB1 | soft tissue tumor | Immunohistochemistry | Soft tissue tumor | Extrarenal rhabdoid tumor | Proximal-type epithelioid sarcoma | proximal-type epithelioid sarcoma | SYNOVIAL SARCOMA | PROGNOSTIC-FACTORS | EXTRASKELETAL MYXOID CHONDROSARCOMA | PATHOLOGY | RENAL-CELL CARCINOMA | IMMUNOHISTOCHEMICAL ANALYSIS | MALIGNANT FIBROUS HISTIOCYTOMA | EPITHELIOID SARCOMA | POLYMERASE CHAIN-REACTION | CENTRAL-NERVOUS-SYSTEM | ATYPICAL TERATOID/RHABDOID TUMORS | Diagnosis, Differential | Molecular Biology | Biomarkers, Tumor - analysis | Humans | Rhabdoid Tumor - chemistry | Chromosomal Proteins, Non-Histone | Child, Preschool | DNA-Binding Proteins - analysis | Infant | Rhabdoid Tumor - pathology | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Sarcoma - pathology | SMARCB1 Protein | Sarcoma - chemistry | Rhabdoid Tumor - genetics | Soft Tissue Neoplasms - chemistry | Soft Tissue Neoplasms - pathology | Cytogenetics | Transcription Factors - analysis | Mutation | Sarcoma - genetics | Child | Soft Tissue Neoplasms - genetics | Sarcoma | Genetic research
Journal Article
Magnetic Resonance in Medical Sciences, ISSN 1347-3182, 2008, Volume 7, Issue 1, pp. 23 - 29
Purpose: To evaluate the usefulness of apparent diffusion coefficient (ADC) for the differential diagnosis of breast tumors and to determine the relation...
apparent diffusion coefficient | neoplasm | MR imaging | breast | cellularity | Neoplasm | Breast | Cellularity | Apparent diffusion coefficient | Breast Neoplasms - surgery | Fibroadenoma - pathology | Adenocarcinoma, Mucinous - pathology | Breast - surgery | Humans | Middle Aged | Adenocarcinoma, Mucinous - surgery | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Fibroadenoma - diagnosis | Diffusion | Breast - pathology | Carcinoma, Ductal, Breast - surgery | Diagnosis, Differential | Fibroadenoma - surgery | Echo-Planar Imaging - methods | Image Processing, Computer-Assisted - methods | Carcinoma, Ductal, Breast - diagnosis | Adenocarcinoma, Mucinous - diagnosis | Breast Neoplasms - pathology | Adolescent | Aged | Breast Neoplasms - diagnosis | Diffusion Magnetic Resonance Imaging - methods
apparent diffusion coefficient | neoplasm | MR imaging | breast | cellularity | Neoplasm | Breast | Cellularity | Apparent diffusion coefficient | Breast Neoplasms - surgery | Fibroadenoma - pathology | Adenocarcinoma, Mucinous - pathology | Breast - surgery | Humans | Middle Aged | Adenocarcinoma, Mucinous - surgery | Aged, 80 and over | Adult | Carcinoma, Ductal, Breast - pathology | Female | Fibroadenoma - diagnosis | Diffusion | Breast - pathology | Carcinoma, Ductal, Breast - surgery | Diagnosis, Differential | Fibroadenoma - surgery | Echo-Planar Imaging - methods | Image Processing, Computer-Assisted - methods | Carcinoma, Ductal, Breast - diagnosis | Adenocarcinoma, Mucinous - diagnosis | Breast Neoplasms - pathology | Adolescent | Aged | Breast Neoplasms - diagnosis | Diffusion Magnetic Resonance Imaging - methods
Journal Article
Human Pathology, ISSN 0046-8177, 2010, Volume 41, Issue 2, pp. 214 - 222
Summary N- myc downstream regulated gene-1 (NDRG1)/Cap43 plays an important role in tumor progression and metastases in many kinds of cancers. Recently, it was...
Pathology | NDRG1/Cap43 | Prognosis | Prostate | Carcinogenesis | E-cadherin | CELLS | PANCREATIC-CANCER | RADICAL PROSTATECTOMY | PATHOLOGY | NDRG1 | BREAST-CANCER | POOR-PROGNOSIS | TUMOR-METASTASIS | DIFFERENTIATION | EXPRESSION | METASTASIS SUPPRESSOR GENE | Immunohistochemistry | Prostatic Neoplasms - metabolism | Cadherins - metabolism | Humans | Cell Cycle Proteins - metabolism | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Intracellular Signaling Peptides and Proteins - metabolism | Prostatic Neoplasms - diagnosis | Chi-Square Distribution | Disease Progression | Disease-Free Survival | Aged | Cell research | Analysis | Oncology, Experimental | Genetic research | Development and progression | Genetic aspects | Research | Universities and colleges | Prostate cancer | Cancer | Medical informatics | Proteins | Medical research | Mortality
Pathology | NDRG1/Cap43 | Prognosis | Prostate | Carcinogenesis | E-cadherin | CELLS | PANCREATIC-CANCER | RADICAL PROSTATECTOMY | PATHOLOGY | NDRG1 | BREAST-CANCER | POOR-PROGNOSIS | TUMOR-METASTASIS | DIFFERENTIATION | EXPRESSION | METASTASIS SUPPRESSOR GENE | Immunohistochemistry | Prostatic Neoplasms - metabolism | Cadherins - metabolism | Humans | Cell Cycle Proteins - metabolism | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Intracellular Signaling Peptides and Proteins - metabolism | Prostatic Neoplasms - diagnosis | Chi-Square Distribution | Disease Progression | Disease-Free Survival | Aged | Cell research | Analysis | Oncology, Experimental | Genetic research | Development and progression | Genetic aspects | Research | Universities and colleges | Prostate cancer | Cancer | Medical informatics | Proteins | Medical research | Mortality
Journal Article
Modern Pathology, ISSN 0893-3952, 07/2010, Volume 23, Issue 7, pp. 981 - 990
Synovial sarcoma is classified as a tumor of uncertain differentiation, and some synovial sarcomas have rhabdoid cells. In previous studies, all malignant...
chromatin remodeling | synovial sarcoma | malignant rhabdoid tumor | SS18-SSX | SMARCB1/INI1 | AGGRESSIVE-BEHAVIOR | SOFT-TISSUE SARCOMAS | FUSION GENE | PATHOLOGY | MALIGNANT RHABDOID TUMORS | SYT | FEATURES | INI1 EXPRESSION | INTERACTS | DISTINCTION | EPITHELIOID SARCOMA | Immunohistochemistry | Biomarkers, Tumor - analysis | Humans | Soft Tissue Neoplasms - metabolism | RNA, Messenger - analysis | Sarcoma, Synovial - metabolism | Sarcoma, Synovial - mortality | Transcription Factors - biosynthesis | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | SMARCB1 Protein | Chromosomal Proteins, Non-Histone - biosynthesis | Soft Tissue Neoplasms - pathology | Survival Analysis | Sarcoma, Synovial - pathology | DNA-Binding Proteins - biosynthesis
chromatin remodeling | synovial sarcoma | malignant rhabdoid tumor | SS18-SSX | SMARCB1/INI1 | AGGRESSIVE-BEHAVIOR | SOFT-TISSUE SARCOMAS | FUSION GENE | PATHOLOGY | MALIGNANT RHABDOID TUMORS | SYT | FEATURES | INI1 EXPRESSION | INTERACTS | DISTINCTION | EPITHELIOID SARCOMA | Immunohistochemistry | Biomarkers, Tumor - analysis | Humans | Soft Tissue Neoplasms - metabolism | RNA, Messenger - analysis | Sarcoma, Synovial - metabolism | Sarcoma, Synovial - mortality | Transcription Factors - biosynthesis | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | SMARCB1 Protein | Chromosomal Proteins, Non-Histone - biosynthesis | Soft Tissue Neoplasms - pathology | Survival Analysis | Sarcoma, Synovial - pathology | DNA-Binding Proteins - biosynthesis
Journal Article
Cancer Science, ISSN 1347-9032, 02/2009, Volume 100, Issue 2, pp. 200 - 208
In the present paper, recent advances in the molecular pathology of soft tissue sarcomas (STS) and the implications for their prognostic value are reviewed,...
GROWTH-FACTOR RECEPTOR | FUSION TRANSCRIPT STRUCTURE | HUMAN SYNOVIAL SARCOMA | MALIGNANT RHABDOID TUMOR | ONCOLOGY | MESSENGER-RNA EXPRESSION | BOX-BINDING PROTEIN-1 | SPORADIC DESMOID TUMORS | SUPPRESSOR GENE-MUTATIONS | NERVE SHEATH TUMORS | MYXOID/ROUND-CELL LIPOSARCOMA | Sarcoma - metabolism | Biomarkers, Tumor - metabolism | Sarcoma - diagnosis | Prognosis | Sarcoma - therapy | Humans | Sarcoma | Epidermal growth factor
GROWTH-FACTOR RECEPTOR | FUSION TRANSCRIPT STRUCTURE | HUMAN SYNOVIAL SARCOMA | MALIGNANT RHABDOID TUMOR | ONCOLOGY | MESSENGER-RNA EXPRESSION | BOX-BINDING PROTEIN-1 | SPORADIC DESMOID TUMORS | SUPPRESSOR GENE-MUTATIONS | NERVE SHEATH TUMORS | MYXOID/ROUND-CELL LIPOSARCOMA | Sarcoma - metabolism | Biomarkers, Tumor - metabolism | Sarcoma - diagnosis | Prognosis | Sarcoma - therapy | Humans | Sarcoma | Epidermal growth factor
Journal Article
Experimental Cell Research, ISSN 0014-4827, 09/2012, Volume 318, Issue 15, pp. 1799 - 1807
There is emerging evidence that human solid tumor cells originate from cancer stem cells (CSCs). In cancer cell lines, tumor-initiating CSCs are mainly found...
Nanog | Proliferation | Cancer stem cells | Gastrointestinal cancer | Nanog P8 | INITIATING CELLS | SELF-RENEWAL | PLURIPOTENCY | IDENTIFICATION | TUMORS | CELL BIOLOGY | STEM-LIKE CELLS | ONCOLOGY | GENE NANOG | ES CELLS | CARCINOMA | EXPRESSION | Immunohistochemistry | Neoplasm Transplantation | RNA, Small Interfering - genetics | Cell Proliferation | Gastrointestinal Neoplasms - genetics | Homeodomain Proteins - metabolism | Humans | Molecular Sequence Data | Male | Transplantation, Heterologous | DNA Primers - genetics | Gastrointestinal Neoplasms - pathology | Transfection | Neoplastic Stem Cells - metabolism | Base Sequence | Neoplastic Stem Cells - pathology | Gastrointestinal Neoplasms - metabolism | Recombinant Proteins - metabolism | Nanog Homeobox Protein | Recombinant Proteins - genetics | Sequence Homology, Nucleic Acid | Homeodomain Proteins - genetics | Mice, Knockout | Animals | Pseudogenes | Homeodomain Proteins - antagonists & inhibitors | Cell Line, Tumor | Mice | Medical law | Cancer cells | Stem cells | Cancer | Gene expression | Digestive system | NUCLEOTIDES | INHIBITION | NEOPLASMS | CELL PROLIFERATION | ANIMAL TISSUES | STEM CELLS | TUMOR CELLS | PROTEINS | 60 APPLIED LIFE SCIENCES
Nanog | Proliferation | Cancer stem cells | Gastrointestinal cancer | Nanog P8 | INITIATING CELLS | SELF-RENEWAL | PLURIPOTENCY | IDENTIFICATION | TUMORS | CELL BIOLOGY | STEM-LIKE CELLS | ONCOLOGY | GENE NANOG | ES CELLS | CARCINOMA | EXPRESSION | Immunohistochemistry | Neoplasm Transplantation | RNA, Small Interfering - genetics | Cell Proliferation | Gastrointestinal Neoplasms - genetics | Homeodomain Proteins - metabolism | Humans | Molecular Sequence Data | Male | Transplantation, Heterologous | DNA Primers - genetics | Gastrointestinal Neoplasms - pathology | Transfection | Neoplastic Stem Cells - metabolism | Base Sequence | Neoplastic Stem Cells - pathology | Gastrointestinal Neoplasms - metabolism | Recombinant Proteins - metabolism | Nanog Homeobox Protein | Recombinant Proteins - genetics | Sequence Homology, Nucleic Acid | Homeodomain Proteins - genetics | Mice, Knockout | Animals | Pseudogenes | Homeodomain Proteins - antagonists & inhibitors | Cell Line, Tumor | Mice | Medical law | Cancer cells | Stem cells | Cancer | Gene expression | Digestive system | NUCLEOTIDES | INHIBITION | NEOPLASMS | CELL PROLIFERATION | ANIMAL TISSUES | STEM CELLS | TUMOR CELLS | PROTEINS | 60 APPLIED LIFE SCIENCES
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 09/2009, Volume 33, Issue 9, pp. 1330 - 1340
Inflammatory pseudotumor (IPT) is a heterogeneous group of lesions occurring in various organs, which is histologically characterized by fibroblastic and...
Immunohistochemistry | IgG4 | Inflammatory pseudotumor | Inflammatory myofibroblastic tumor | SURGERY | LUNG | DIAGNOSIS | PLASMA-CELL GRANULOMA | FUSION | inflammatory myofibroblastic tumor | FIBROUS HISTIOCYTOMA | PATHOLOGY | INFILTRATION | AUTOIMMUNE PANCREATITIS | inflammatory pseudotumor | immunohistochemistry | SPECTRUM | EXPRESSION | EPSTEIN-BARR-VIRUS | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Child, Preschool | Infant | Male | Dacryocystitis - immunology | Retroperitoneal Fibrosis - pathology | Sclerosis | Plasma Cells - pathology | Young Adult | Anaplastic Lymphoma Kinase | Phlebitis - immunology | Immunoglobulin G - immunology | Pancreatitis - immunology | Adult | Female | Phlebitis - pathology | Autoimmune Diseases - pathology | Child | Autoimmune Diseases - immunology | Receptor Protein-Tyrosine Kinases | Cholangitis, Sclerosing - pathology | Sialadenitis - pathology | Granuloma, Plasma Cell - pathology | Cholangitis, Sclerosing - immunology | Pancreatitis - pathology | Retroperitoneal Fibrosis - immunology | Aged | Granuloma, Plasma Cell - metabolism | Chronic Disease | Dacryocystitis - pathology | Sialadenitis - immunology
Immunohistochemistry | IgG4 | Inflammatory pseudotumor | Inflammatory myofibroblastic tumor | SURGERY | LUNG | DIAGNOSIS | PLASMA-CELL GRANULOMA | FUSION | inflammatory myofibroblastic tumor | FIBROUS HISTIOCYTOMA | PATHOLOGY | INFILTRATION | AUTOIMMUNE PANCREATITIS | inflammatory pseudotumor | immunohistochemistry | SPECTRUM | EXPRESSION | EPSTEIN-BARR-VIRUS | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Child, Preschool | Infant | Male | Dacryocystitis - immunology | Retroperitoneal Fibrosis - pathology | Sclerosis | Plasma Cells - pathology | Young Adult | Anaplastic Lymphoma Kinase | Phlebitis - immunology | Immunoglobulin G - immunology | Pancreatitis - immunology | Adult | Female | Phlebitis - pathology | Autoimmune Diseases - pathology | Child | Autoimmune Diseases - immunology | Receptor Protein-Tyrosine Kinases | Cholangitis, Sclerosing - pathology | Sialadenitis - pathology | Granuloma, Plasma Cell - pathology | Cholangitis, Sclerosing - immunology | Pancreatitis - pathology | Retroperitoneal Fibrosis - immunology | Aged | Granuloma, Plasma Cell - metabolism | Chronic Disease | Dacryocystitis - pathology | Sialadenitis - immunology
Journal Article
Modern Pathology, ISSN 0893-3952, 05/2006, Volume 19, Issue 5, pp. 738 - 745
The chemokine, CXCL12, and its receptor, CXCR4, have recently been shown to play an important role in metastasis of several kinds of carcinoma. It has also...
CXCR4 | Lung metastasis | Microvessel density | Osteosarcoma | VEGF | lung metastasis | TUMOR PROGRESSION | CHEMOKINE RECEPTOR CXCR4 | INVOLVEMENT | microvessel density | PATHOLOGY | RELAPSE | CANCER METASTASIS | POOR-PROGNOSIS | SQUAMOUS-CELL CARCINOMA | osteosarcoma | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Antigens, CD34 - analysis | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Bone Neoplasms - pathology | Bone Neoplasms - metabolism | Neovascularization, Pathologic - pathology | Ki-67 Antigen - analysis | Lung Neoplasms - secondary | Receptors, CXCR4 - biosynthesis | Bone Neoplasms - blood supply | Adolescent | Survival Analysis | Vascular Endothelial Growth Factors - biosynthesis | Adult | Female | Aged | Neovascularization, Pathologic - metabolism | Osteosarcoma - secondary | Child | Osteosarcoma - metabolism
CXCR4 | Lung metastasis | Microvessel density | Osteosarcoma | VEGF | lung metastasis | TUMOR PROGRESSION | CHEMOKINE RECEPTOR CXCR4 | INVOLVEMENT | microvessel density | PATHOLOGY | RELAPSE | CANCER METASTASIS | POOR-PROGNOSIS | SQUAMOUS-CELL CARCINOMA | osteosarcoma | ENDOTHELIAL GROWTH-FACTOR | Immunohistochemistry | Antigens, CD34 - analysis | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Bone Neoplasms - pathology | Bone Neoplasms - metabolism | Neovascularization, Pathologic - pathology | Ki-67 Antigen - analysis | Lung Neoplasms - secondary | Receptors, CXCR4 - biosynthesis | Bone Neoplasms - blood supply | Adolescent | Survival Analysis | Vascular Endothelial Growth Factors - biosynthesis | Adult | Female | Aged | Neovascularization, Pathologic - metabolism | Osteosarcoma - secondary | Child | Osteosarcoma - metabolism
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2005, Volume 11, Issue 21, pp. 7785 - 7793
Recent microarray analyses showed that the S100 family contains members that are candidate diagnostic markers or therapeutic targets. In the present study, to...
S100A6 | pancreatic cancer | pancreatic juice | PanIN | microdissection | PROTEIN | K-RAS GENE | ONCOLOGY | ADENOCARCINOMA | TELOMERASE ACTIVITY | JUICE | ACTIVATING TRANSCRIPTION FACTOR-3 | CELL-LINES | EXPRESSION | CARCINOMA | TUMOR-STROMAL INTERACTIONS | Immunohistochemistry | Oligonucleotides - chemistry | Up-Regulation | Cell Proliferation | Pancreatic Neoplasms - metabolism | Oligonucleotide Array Sequence Analysis | Pancreatic Neoplasms - diagnosis | Down-Regulation | Humans | Pancreatic Neoplasms - pathology | Cell Cycle Proteins - metabolism | Gene Expression Regulation, Neoplastic | S100 Calcium Binding Protein A6 | S100 Proteins - metabolism | Cell Cycle Proteins - biosynthesis | Pancreas - metabolism | RNA, Messenger - metabolism | Biomarkers, Tumor | Chemotactic Factors - biosynthesis | RNA Interference | Time Factors | Cell Line, Tumor | S100 Proteins - biosynthesis | RNA, Small Interfering - metabolism
S100A6 | pancreatic cancer | pancreatic juice | PanIN | microdissection | PROTEIN | K-RAS GENE | ONCOLOGY | ADENOCARCINOMA | TELOMERASE ACTIVITY | JUICE | ACTIVATING TRANSCRIPTION FACTOR-3 | CELL-LINES | EXPRESSION | CARCINOMA | TUMOR-STROMAL INTERACTIONS | Immunohistochemistry | Oligonucleotides - chemistry | Up-Regulation | Cell Proliferation | Pancreatic Neoplasms - metabolism | Oligonucleotide Array Sequence Analysis | Pancreatic Neoplasms - diagnosis | Down-Regulation | Humans | Pancreatic Neoplasms - pathology | Cell Cycle Proteins - metabolism | Gene Expression Regulation, Neoplastic | S100 Calcium Binding Protein A6 | S100 Proteins - metabolism | Cell Cycle Proteins - biosynthesis | Pancreas - metabolism | RNA, Messenger - metabolism | Biomarkers, Tumor | Chemotactic Factors - biosynthesis | RNA Interference | Time Factors | Cell Line, Tumor | S100 Proteins - biosynthesis | RNA, Small Interfering - metabolism
Journal Article
Human Pathology, ISSN 0046-8177, 2011, Volume 42, Issue 10, pp. 1531 - 1538
Summary Portal venous invasion is one of the most important prognostic factors after surgical resection of hepatocellular carcinoma. Microscopic portal venous...
Pathology | Vascular invasion | Hepatocellular carcinoma | Portal venous invasion | SURVIVAL | SYSTEM | RESECTION | HEPATECTOMY | CIRRHOSIS | PATHOLOGY | Prognosis | Carcinoma, Hepatocellular - diagnosis | Neoplasm Invasiveness | Humans | Male | Survival Rate | Disease-Free Survival | Liver Neoplasms - diagnosis | Analysis of Variance | Carcinoma, Hepatocellular - pathology | Female | Liver Neoplasms - pathology | Portal Vein - pathology | Aged | Liver cancer | Analysis | Hepatoma | Studies | Tumors | Veins & arteries | Cancer
Pathology | Vascular invasion | Hepatocellular carcinoma | Portal venous invasion | SURVIVAL | SYSTEM | RESECTION | HEPATECTOMY | CIRRHOSIS | PATHOLOGY | Prognosis | Carcinoma, Hepatocellular - diagnosis | Neoplasm Invasiveness | Humans | Male | Survival Rate | Disease-Free Survival | Liver Neoplasms - diagnosis | Analysis of Variance | Carcinoma, Hepatocellular - pathology | Female | Liver Neoplasms - pathology | Portal Vein - pathology | Aged | Liver cancer | Analysis | Hepatoma | Studies | Tumors | Veins & arteries | Cancer
Journal Article
Human Pathology, ISSN 0046-8177, 2010, Volume 41, Issue 6, pp. 824 - 831
Summary Intraductal papillary mucinous neoplasms of the pancreas are subclassified based on morphological features, and different immunohistochemical profiles...
Pathology | Mucin expression | S100P | IPMN | Pancreatic cancer | ADENOCARCINOMA | PANCREATIC-CANCER | CONSENSUS | CLASSIFICATION | PATHOLOGY | TUMORS | LESIONS | CARCINOGENESIS | GENE-EXPRESSION | SURGICAL RESECTION | CARCINOMA | Immunohistochemistry | Pancreatic Neoplasms - metabolism | Adenocarcinoma, Mucinous - pathology | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Carcinoma, Pancreatic Ductal - metabolism | Male | Carcinoma, Papillary - metabolism | Aged, 80 and over | Carcinoma, Pancreatic Ductal - diagnosis | Female | Diagnosis, Differential | Epithelium - pathology | Calcium-Binding Proteins - biosynthesis | Epithelium - metabolism | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | Pancreatic Neoplasms - pathology | Pancreas - pathology | Pancreas - metabolism | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Papillary - pathology | Mucin-1 - biosynthesis | Adenocarcinoma, Mucinous - diagnosis | Adenocarcinoma, Mucinous - metabolism | Aged | Mucin 5AC - biosynthesis | Mucin-2 - biosynthesis | Biomarkers, Tumor - biosynthesis | Carcinoma, Papillary - diagnosis | Mucins | Proteins | Pancreas | Cervical cancer | Index Medicus
Pathology | Mucin expression | S100P | IPMN | Pancreatic cancer | ADENOCARCINOMA | PANCREATIC-CANCER | CONSENSUS | CLASSIFICATION | PATHOLOGY | TUMORS | LESIONS | CARCINOGENESIS | GENE-EXPRESSION | SURGICAL RESECTION | CARCINOMA | Immunohistochemistry | Pancreatic Neoplasms - metabolism | Adenocarcinoma, Mucinous - pathology | Pancreatic Neoplasms - diagnosis | Humans | Middle Aged | Carcinoma, Pancreatic Ductal - metabolism | Male | Carcinoma, Papillary - metabolism | Aged, 80 and over | Carcinoma, Pancreatic Ductal - diagnosis | Female | Diagnosis, Differential | Epithelium - pathology | Calcium-Binding Proteins - biosynthesis | Epithelium - metabolism | Neoplasm Invasiveness | Neoplasm Proteins - biosynthesis | Pancreatic Neoplasms - pathology | Pancreas - pathology | Pancreas - metabolism | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Papillary - pathology | Mucin-1 - biosynthesis | Adenocarcinoma, Mucinous - diagnosis | Adenocarcinoma, Mucinous - metabolism | Aged | Mucin 5AC - biosynthesis | Mucin-2 - biosynthesis | Biomarkers, Tumor - biosynthesis | Carcinoma, Papillary - diagnosis | Mucins | Proteins | Pancreas | Cervical cancer | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2003, Volume 9, Issue 7, pp. 2657 - 2664
Purpose: Snail protein is a suppressive transcriptional factor of E-cadherin that mediates cell-to-cell adhesion, tumor progression, and metastases. We...
INACTIVATION | METHYLATION | INVASION | CELL-ADHESION SYSTEM | ONCOLOGY | EPITHELIAL-MESENCHYMAL TRANSITIONS | MUTATIONS | BETA-CATENIN | ALTERED EXPRESSION | E-CADHERIN GENE | Immunohistochemistry | Green Fluorescent Proteins | Cadherins - metabolism | Bile Ducts - metabolism | Humans | Middle Aged | Male | RNA, Messenger - metabolism | DNA-Binding Proteins - metabolism | Tissue Distribution | Neoplasm Metastasis | In Situ Hybridization | Transfection | Cloning, Molecular | Female | Liver Neoplasms - pathology | Transcription, Genetic | Retrospective Studies | Snail Family Transcription Factors | Protein Structure, Tertiary | DNA-Binding Proteins - physiology | Transcription Factors - physiology | Neoplasm Invasiveness | Down-Regulation | Reverse Transcriptase Polymerase Chain Reaction | Disease Progression | Transcription Factors - metabolism | Liver Neoplasms - metabolism | Aged | DNA, Complementary - metabolism | Leukocytes - metabolism | Microscopy, Fluorescence | Carcinoma, Hepatocellular - metabolism | Luminescent Proteins - metabolism
INACTIVATION | METHYLATION | INVASION | CELL-ADHESION SYSTEM | ONCOLOGY | EPITHELIAL-MESENCHYMAL TRANSITIONS | MUTATIONS | BETA-CATENIN | ALTERED EXPRESSION | E-CADHERIN GENE | Immunohistochemistry | Green Fluorescent Proteins | Cadherins - metabolism | Bile Ducts - metabolism | Humans | Middle Aged | Male | RNA, Messenger - metabolism | DNA-Binding Proteins - metabolism | Tissue Distribution | Neoplasm Metastasis | In Situ Hybridization | Transfection | Cloning, Molecular | Female | Liver Neoplasms - pathology | Transcription, Genetic | Retrospective Studies | Snail Family Transcription Factors | Protein Structure, Tertiary | DNA-Binding Proteins - physiology | Transcription Factors - physiology | Neoplasm Invasiveness | Down-Regulation | Reverse Transcriptase Polymerase Chain Reaction | Disease Progression | Transcription Factors - metabolism | Liver Neoplasms - metabolism | Aged | DNA, Complementary - metabolism | Leukocytes - metabolism | Microscopy, Fluorescence | Carcinoma, Hepatocellular - metabolism | Luminescent Proteins - metabolism
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 01/2008, Volume 97, Issue 1, pp. 74 - 81
Background Angiosarcomas are malignant mesenchymal neoplasms, including sarcomas of presumptive vascular endothelial origin and sarcomas of probable lymphatic...
VEGF‐C | VEGFR‐3 | vascular neoplasms | skin neoplasms | VEGF‐A | soft tissue neoplasms | Stewart‐Treves syndrome | Stewart-Treves syndrome | Skin neoplasms | VEGFR-3 | Vascular neoplasms | VEGF-C | Soft tissue neoplasms | VEGF-A | SURGERY | TYROSINE KINASE | CUTANEOUS ANGIOSARCOMA | TUMORS | LYMPH-NODE METASTASIS | KAPOSIS-SARCOMA | ONCOLOGY | STEWART-TREVES-SYNDROME | LYMPHANGIOGENESIS | EXPRESSION | SOFT-TISSUE SARCOMA | Immunohistochemistry | Hemangiosarcoma - pathology | Prognosis | Receptors, Vascular Endothelial Growth Factor - analysis | Humans | Middle Aged | Male | Survival Rate | Vascular Endothelial Growth Factor A - analysis | Hemangiosarcoma - chemistry | Hemangiosarcoma - mortality | Aged, 80 and over | Adult | Female | Aged
VEGF‐C | VEGFR‐3 | vascular neoplasms | skin neoplasms | VEGF‐A | soft tissue neoplasms | Stewart‐Treves syndrome | Stewart-Treves syndrome | Skin neoplasms | VEGFR-3 | Vascular neoplasms | VEGF-C | Soft tissue neoplasms | VEGF-A | SURGERY | TYROSINE KINASE | CUTANEOUS ANGIOSARCOMA | TUMORS | LYMPH-NODE METASTASIS | KAPOSIS-SARCOMA | ONCOLOGY | STEWART-TREVES-SYNDROME | LYMPHANGIOGENESIS | EXPRESSION | SOFT-TISSUE SARCOMA | Immunohistochemistry | Hemangiosarcoma - pathology | Prognosis | Receptors, Vascular Endothelial Growth Factor - analysis | Humans | Middle Aged | Male | Survival Rate | Vascular Endothelial Growth Factor A - analysis | Hemangiosarcoma - chemistry | Hemangiosarcoma - mortality | Aged, 80 and over | Adult | Female | Aged
Journal Article